d-dimer is a predictor of clot resolution in patients with pulmonary thromboembolism: A retrospective cohort study

Clin Respir J. 2020 Jun;14(6):549-556. doi: 10.1111/crj.13167. Epub 2020 Feb 28.

Abstract

Background: This study assessed predictors of pulmonary thromboembolism (PE) resolution and their implications for clinical outcome.

Method: A total of 150 patients with acute PE diagnosed by computed tomography pulmonary angiography (CTPA) were included. All patients received anticoagulant therapy for 3-6 months and were followed-up for at least 2 years. d-dimer levels in plasma were assayed at the first admission and during follow-up.

Results: The rate of CTPA-confirmed PE resolution was 48.67% at 6 months, 68% at 12 months, and 78.67% at 24 months. Thirty-nine patients had recurrent thrombosis after anticoagulation therapy was stopped, whereas 93 patients had complete resolution. The initial d-dimer level positively correlated with the pulmonary artery obstruction index (PAOI) (r = 0.21; P = 0.015), but did not significantly differ between patients experiencing resolution or recurrence. In contrast, the follow-up mean d-dimer level was significantly higher in the recurrent group (P < 0.001), and this level was an independent risk factor for recurrent PE after the termination of anticoagulation treatment (OR 1.003, 95%CI 1.002 to 1.004; P < 0.001). Higher initial thromboembolic burden measured by PAOI was associated with residual thromboemboli (P = 0.004) and recurrence (P = 0.03), but was not an independent risk factor for either.

Conclusions: Elevated d-dimer is an independent risk factor for PE recurrence. A higher initial thromboembolic burden may be associated with unresolved thromboemboli or recurrence.

Keywords: PAOI; d-dimer; pulmonary thromboembolism; recurrence; resolution.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Anticoagulants / pharmacology*
  • Anticoagulants / therapeutic use
  • Clot Retraction / drug effects*
  • Computed Tomography Angiography / methods
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pulmonary Artery / diagnostic imaging
  • Pulmonary Artery / pathology
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / drug therapy
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Thrombosis / metabolism
  • Tomography, X-Ray Computed / methods
  • Venous Thrombosis / blood
  • Venous Thrombosis / complications
  • Venous Thrombosis / diagnosis

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D